Canada OKs Pfizer-BioNTech COVID-19 booster dose for 5 to 11 year olds

Canada approves 1st COVID-19 booster for kids 5-11

OTTAWA, Aug. 19 (Xinhua) -- Canada's drug regulator announced Friday it has authorized Pfizer-BioNTech Comirnaty COVID-19 vaccine for use as a booster dose in children aged 5 to 11 years. Read full story

Pfizer booster dose approved for kids between five and 11 years old - Cowichan Valley CitizenCowichan Valley Citizen

NACI: high-risk kids “should” be offered one and others “may” be offered one

Pfizer booster dose approved for kids between five and 11 years old - Sicamous Eagle Valley NewsSicamous Eagle Valley News

NACI: high-risk kids “should” be offered one and others “may” be offered one

Pfizer booster dose approved for kids between five and 11 years old

Health Canada has authorized a booster dose of the Pfizer-BioNTech vaccine for children between five and 11 years old, chief public health officer Dr. Theresa Tam said Friday. Tam said the National Advisory Committee on Immunization recommends children with underlying health conditions should be off...

Pfizer booster dose approved for kids between five and 11 years old

OTTAWA -- Health Canada has authorized a booster dose of the Pfizer-BioNTech vaccine for children between five and 11 years old, chief public health officer Dr. Theresa Tam said Friday. Read More

Canada OKs Pfizer COVID-19 booster for kids 5-11, sees monkeypox cases slow

Canada's health ministry on Friday (Aug 19) said it had authorised the use of Pfizer's and BioNTech's COVID-19 vaccine as a booster for children five to 11 years old at least six months after receiving their initial two doses. The authorisation for a booster shot was granted after a thorough, independent r